Report Description
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.

The personalized cell therapy is mainly developed for the treatment of high unmet need disease such as cancer, also it comprises drugs for treatment of other diseases such as autoimmune disease, cardiovascular, neurologic and inflammatory disease.

Personalized cell therapy also finds application in the area of platelet transfusions, packed red cell transfusions, bone marrow transplantation and in organ transplantation.

Personalized Cell Therapy Market Dynamics
The continuous development in science and technology sector has led to development of various novel individualized drugs, which would fuel growth of the personalized cell therapy market in the near future. Personalized cell therapy favors the accurate diagnosis of the disease and active monitoring of the treatment response and disease progression. This allows for early detection of diseases at molecular level and enables the physician to prepare the treatment regime for the specific patient requirement. This helps the patient recover at a significant pace and also helps avoid any major side effects, as individualized cell therapy is based on patient’s genomics.
Newly introduced procedures and techniques are expected to favor increase in adoption rate for personalized cell therapy in the near future. New ventures in the biologics industry are expected to be a major push for the market to grow, for instance, a high demand for biological compounds is influencing organizations to manufacture products using the biopharmaceutical process, which is further administered through injections.
Large untapped markets in emerging economies can be capitalized upon through favorable product pricing, which further can facilitate the increase in number of procedures worldwide. Also, as the manufacturing cost requirement is low in emerging economies as compare to developed countries this will help to grow the market in emerging economies such as India and China.
Market Taxonomy
This report segments the global personalized cell therapy market on the basis of applications, therapeutic area and geography. On the basis of application, the market is categorized into Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions and Organ Transplantation. Among these applications, Platelet Transfusions segment dominate the personalized cell therapy market. On the basis of therapeutic area, the market is divided into Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes and Cancer. On the basis of geography, the market is divided into 6 Regions. Among all regions, North America dominated the personalized cell therapy market, as more than 200 companies engaged in development of personalized cell therapy products in U.S. Also, better healthcare amenities and high prevalence of cancer in the region is expected to boost overall sales of autologous cell therapy products.

Key features of the study:

  • This report provides in-depth analysis of the personalized cell therapy market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2024)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global personalized cell therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
  • The global personalized cell therapy market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, CROs, medical device companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the personalized cell therapy market


Detailed Segmentation:

  • Global Personalized Cell Therapy Market, By Applications:
  • ·Platelet Transfusions
  • ·Bone Marrow Transplantation
  • ·Packed Red Cell Transfusions
  • ·Organ Transplantation
  • Global Personalized Cell Therapy Market, By Therapeutic Area:
  • ·Cardiovascular Diseases
  • ·Neurological Disorders
  • ·Inflammatory Diseases
  • ·Diabetes
  • ·Cancer
  • Global Personalized Cell Therapy Market, By Geography:
  • ·North America


o North America Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o North America Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o North America Personalized Cell Therapy Market, By Country:
o U.S.
o Canada

  • ·Europe


o Europe Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o Europe Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o Europe Personalized Cell Therapy Market, By Country:
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe

  • ·Asia-Pacific


o Asia-Pacific Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o Asia-Pacific Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o Asia-Pacific Personalized Cell Therapy Market, By Country:
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia-Pacific

  • ·Latin America


o Latin America Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o Latin America Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o Latin America Personalized Cell Therapy Market, By Country:
o Brazil
o Mexico
o Argentina
o Rest of Latin America

  • ·Middle East


o Middle East Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o Middle East Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o Middle East Personalized Cell Therapy Market, By Country:
o GCC
o Israel
o Rest of Middle-East

  • ·Africa


o Africa Personalized Cell Therapy Market, By Applications:
o Platelet Transfusions
o Bone Marrow Transplantation
o Packed Red Cell Transfusions
o Organ Transplantation
o Africa Personalized Cell Therapy Market, By Therapeutic Area:
o Cardiovascular Diseases
o Neurological Disorders
o Inflammatory Diseases
o Diabetes
o Cancer
o Africa Personalized Cell Therapy Market, By Country:
o North Africa
o Central Africa
o South Africa

  • Company Profiles
  • ·Cytori Therapeutics Inc. *


o Company Overview
o Product Portfolio
o Strategies Presence
o Key Developments

  • ·Bellicum Pharmaceuticals, Inc.
  • ·Saneron CCEL Therapeutics, Inc.
  • ·MolMed S.p.A.
  • ·Vericel Corporation


?*? marked represents similar segmentation in other categories in the respective section.